Report Summary
Eternity Insights has published a new study on Europe Breast Cancer Predictive Genetic Testing Market focusing on key segments as by Type (High Penetrant Genes, Intermediate Penetrant Genes, Low Penetrant Genes, Other), by Application (Hospitals, Clinics, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the Europe Breast Cancer Predictive Genetic Testing Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Europe Breast Cancer Predictive Genetic Testing Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Europe Breast Cancer Predictive Genetic Testing Market Size, 2018-2028 (USD Million)
To learn more about this report
Europe Breast Cancer Predictive Genetic Testing Market Segmentation:
Europe Breast Cancer Predictive Genetic Testing Market, By Type
- High Penetrant Genes
- Intermediate Penetrant Genes
- Low Penetrant Genes
- Other
Europe Breast Cancer Predictive Genetic Testing Market, By Application
To learn more about this report
The report will include market size and forecast for Europe Breast Cancer Predictive Genetic Testing market for below-listed countries across each region.
Europe (Germany, France, Italy, UK, Spain, and the Rest of Europe).
Europe Breast Cancer Predictive Genetic Testing Market Taxonomy:
To learn more about this report
Europe Breast Cancer Predictive Genetic Testing Market Competitive Landscape
The Europe Breast Cancer Predictive Genetic Testing market analysis report covers detailed analysis of competitive scenarios. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Roche
- Thermo Fisher Scientific
- PerkinElmer
- Quest Diagnostics
- Myriad Genetics
- Iverson Genetics
- Cancer Genetics
- OncoCyte Corporation
- NeoGenomics
- Invitae
- Other Players of Specific Interest can be added based on the requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report Coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
High Penetrant Genes, Intermediate Penetrant Genes, Low Penetrant Genes, Other |
| By Application Outlook |
Hospitals, Clinics, Other |
| Regional scope |
Europe |
| Country scope |
U.K., Germany, France, BENELUX |
| Key companies profiled |
Roche, Thermo Fisher Scientific, PerkinElmer, Quest Diagnostics, Myriad Genetics, Iverson Genetics, Cancer Genetics, OncoCyte Corporation, NeoGenomics, Invitae |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stakeholders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Breast Cancer Predictive Genetic Testing Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 High Penetrant Genes Market Performance (Volume)
2.1.2 Intermediate Penetrant Genes Market Performance (Volume)
2.1.3 Low Penetrant Genes Market Performance (Volume)
2.2 Overall Market Performance(Value)
2.2.1 High Penetrant Genes Market Performance (Value)
2.2.2 Intermediate Penetrant Genes Market Performance (Value)
2.2.3 Low Penetrant Genes Market Performance (Value)
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Hospitals Market Performance (Volume)
3.1.2 Clinics Market Performance (Volume)
3.1.3 Other Market Performance (Volume)
4 Manufacturers Profiles/Analysis
4.1 Roche
4.1.1 Roche Profiles
4.1.2 Roche Product Information
4.1.3 Roche Breast Cancer Predictive Genetic Testing Business Performance
4.1.4 Roche Breast Cancer Predictive Genetic Testing Business Development and Market Status
4.2 Thermo Fisher Scientific
4.2.1 Thermo Fisher Scientific Profiles
4.2.2 Thermo Fisher Scientific Product Information
4.2.3 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Business Performance
4.2.4 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Business Development and Market Status
4.3 PerkinElmer
4.3.1 PerkinElmer Profiles
4.3.2 PerkinElmer Product Information
4.3.3 PerkinElmer Breast Cancer Predictive Genetic Testing Business Performance
4.3.4 PerkinElmer Breast Cancer Predictive Genetic Testing Business Development and Market Status
4.4 Quest Diagnostics
4.4.1 Quest Diagnostics Profiles
4.4.2 Quest Diagnostics Product Information
4.4.3 Quest Diagnostics Breast Cancer Predictive Genetic Testing Business Performance
4.4.4 Quest Diagnostics Breast Cancer Predictive Genetic Testing Business Development and Market Status
4.5 Myriad Genetics
4.5.1 Myriad Genetics Profiles
4.5.2 Myriad Genetics Product Information
4.5.3 Myriad Genetics Breast Cancer Predictive Genetic Testing Business Performance
4.5.4 Myriad Genetics Breast Cancer Predictive Genetic Testing Business Development and Market Status
4.6 Iverson Genetics
4.6.1 Iverson Genetics Profiles
4.6.2 Iverson Genetics Product Information
4.6.3 Iverson Genetics Breast Cancer Predictive Genetic Testing Business Performance
4.6.4 Iverson Genetics Breast Cancer Predictive Genetic Testing Business Development and Market Status
4.7 Cancer Genetics
4.7.1 Cancer Genetics Profiles
4.7.2 Cancer Genetics Product Information
4.7.3 Cancer Genetics Breast Cancer Predictive Genetic Testing Business Performance
4.7.4 Cancer Genetics Breast Cancer Predictive Genetic Testing Business Development and Market Status
4.8 OncoCyte Corporation
4.8.1 OncoCyte Corporation Profiles
4.8.2 OncoCyte Corporation Product Information
4.8.3 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Business Performance
4.8.4 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Business Development and Market Status
4.9 NeoGenomics
4.9.1 NeoGenomics Profiles
4.9.2 NeoGenomics Product Information
4.9.3 NeoGenomics Breast Cancer Predictive Genetic Testing Business Performance
4.9.4 NeoGenomics Breast Cancer Predictive Genetic Testing Business Development and Market Status
4.10 Invitae
4.10.1 Invitae Profiles
4.10.2 Invitae Product Information
4.10.3 Invitae Breast Cancer Predictive Genetic Testing Business Performance
4.10.4 Invitae Breast Cancer Predictive Genetic Testing Business Development and Market Status
5 Market Performance for Manufacturers
5.1 Europe Breast Cancer Predictive Genetic Testing Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Europe Breast Cancer Predictive Genetic Testing Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Europe Breast Cancer Predictive Genetic Testing Price (USD/Unit) of Manufacturers 2014-2020
5.4 Europe Breast Cancer Predictive Genetic Testing Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 Germany Market Performance for Manufacturers
6.1.1 Germany Breast Cancer Predictive Genetic Testing Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 Germany Breast Cancer Predictive Genetic Testing Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 Germany Breast Cancer Predictive Genetic Testing Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 Germany Breast Cancer Predictive Genetic Testing Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 UK Market Performance for Manufacturers
6.2.1 UK Breast Cancer Predictive Genetic Testing Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 UK Breast Cancer Predictive Genetic Testing Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 UK Breast Cancer Predictive Genetic Testing Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 UK Breast Cancer Predictive Genetic Testing Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 France Market Performance for Manufacturers
6.3.1 France Breast Cancer Predictive Genetic Testing Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 France Breast Cancer Predictive Genetic Testing Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 France Breast Cancer Predictive Genetic Testing Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 France Breast Cancer Predictive Genetic Testing Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Russia Market Performance for Manufacturers
6.4.1 Russia Breast Cancer Predictive Genetic Testing Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Russia Breast Cancer Predictive Genetic Testing Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Russia Breast Cancer Predictive Genetic Testing Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Russia Breast Cancer Predictive Genetic Testing Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Benelux Market Performance for Manufacturers
6.5.1 Benelux Breast Cancer Predictive Genetic Testing Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Benelux Breast Cancer Predictive Genetic Testing Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Benelux Breast Cancer Predictive Genetic Testing Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Benelux Breast Cancer Predictive Genetic Testing Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 Italy Market Performance for Manufacturers
6.6.1 Italy Breast Cancer Predictive Genetic Testing Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 Italy Breast Cancer Predictive Genetic Testing Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 Italy Breast Cancer Predictive Genetic Testing Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 Italy Breast Cancer Predictive Genetic Testing Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Spain Market Performance for Manufacturers
6.7.1 Spain Breast Cancer Predictive Genetic Testing Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Spain Breast Cancer Predictive Genetic Testing Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Spain Breast Cancer Predictive Genetic Testing Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Spain Breast Cancer Predictive Genetic Testing Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 Market Performance for Manufacturers
6.8.1 Breast Cancer Predictive Genetic Testing Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 Breast Cancer Predictive Genetic Testing Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 Breast Cancer Predictive Genetic Testing Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 Breast Cancer Predictive Genetic Testing Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Europe Breast Cancer Predictive Genetic Testing Market Performance (Sales Point)
7.1 Europe Breast Cancer Predictive Genetic Testing Sales (K Units) and Market Share by Regions 2014-2020
7.2 Europe Breast Cancer Predictive Genetic Testing Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Europe Breast Cancer Predictive Genetic Testing Price (USD/Unit) by Regions 2014-2020
7.4 Europe Breast Cancer Predictive Genetic Testing Gross Margin by Regions 2014-2020
8 Development Trend for Regions (Sales Point)
8.1 Europe Breast Cancer Predictive Genetic Testing Sales and Growth, Sales Value and Growth Rate2014-2020
8.2 Germany Breast Cancer Predictive Genetic Testing Sales and Growth, Sales Value and Growth Rate2014-2020
8.3 UK Breast Cancer Predictive Genetic Testing Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 France Breast Cancer Predictive Genetic Testing Sales and Growth, Sales Value and Growth Rate2014-2020
8.5 Russia Breast Cancer Predictive Genetic Testing Sales and Growth, Sales Value and Growth Rate2014-2020
8.6 Benelux Breast Cancer Predictive Genetic Testing Sales and Growth, Sales Value and Growth Rate2014-2020
8.7 Italy Breast Cancer Predictive Genetic Testing Sales and Growth, Sales Value and Growth Rate2014-2020
8.8 Spain Breast Cancer Predictive Genetic Testing Sales and Growth, Sales Value and Growth Rate2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 Hospitals Industry
11.2 Clinics Industry
11.3 Other Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Europe Breast Cancer Predictive Genetic Testing Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Europe Breast Cancer Predictive Genetic Testing Sales (K Units) and Growth Rate 2021-2026
12.1.3 Germany Breast Cancer Predictive Genetic Testing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 UK Breast Cancer Predictive Genetic Testing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 France Breast Cancer Predictive Genetic Testing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Russia Breast Cancer Predictive Genetic Testing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Benelux Breast Cancer Predictive Genetic Testing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 Italy Breast Cancer Predictive Genetic Testing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Spain Breast Cancer Predictive Genetic Testing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 High Penetrant Genes Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.3 Intermediate Penetrant Genes Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.4 Low Penetrant Genes Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.3 Sales Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Hospitals Sales and and Growth Rate 2021-2026
12.3.3 Clinics Sales and and Growth Rate 2021-2026
12.3.4 Other Sales and and Growth Rate 2021-2026
12.4 Price (USD/Unit) and Gross Profit Forecast
12.4.1 Europe Breast Cancer Predictive Genetic Testing Price (USD/Unit) Trend 2021-2026
12.4.2 Europe Breast Cancer Predictive Genetic Testing Gross Profit Trend 2021-2026
13 Conclusion
